The good news for any holders of Mckesson (NYQ:MCK) is that the price is currently trading close to a 52 week high, with the share price up by around 7.87% to $334 over the past week. For investors holding the stock (or considering bu...
|Type||Buy / Hold / Sell|
|Year End 31st Mar||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for MCK
As any reader of this is probably aware, shares in Mckesson (NYQ:MCK) are currently trading close to a 52 week high, with the share price up by around 3.82% to $310.5 over the past week. On a one-month basis, the Mckesson price has ris...
Shares in Mckesson (NYQ:MCK) are currently trading at 156.32 but the question for investors is how much the market chaos of 2020 will impact on its price. The answer comes down to judging whether Mckesson is well placed to ride out eco...
Shares in Mckesson (NYQ:MCK) are currently trading at 158.67 but the question for investors is how much the market chaos of 2020 will impact on its price. The answer comes down to judging whether Mckesson is well placed to ride out eco...
“Most bosses rise to the top because they have excelled in an area such as marketing, production, engineering, administration or, sometimes, institutional politics Once they become CEOs, they face new responsibilities. They now must m...
McKesson Corporation is diversified healthcare services provider. The Company is focused on providing health information technology, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides services to wholesale, institutional, in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.
- Edward Mueller NEC (74)
- Brian Tyler CEO (54)
- Britt Vitalone CFO (52)
- Tracy Faber CHO (51)
- Nancy Flores EVP (54)
- Lori Schechter EVP (59)
- Tom Rodgers EVP (50)
- Kevin Emerson SVP (49)
- James Hinton DRC
- Kathleen Wilson - Thompson DRC
- Richard Carmona IND
- Dominic Caruso IND (64)
- Donald Knauss IND (70)
- Brad Lerman IND (64)
- Linda Mantia IND (52)
- Maria Martinez IND (63)
- Susan Salka IND (56)
Upcoming Events for MCK
Dividend For M1CK34.SA - 0.5888 BRL
Dividend For MCK.N - 0.4700 USD
McKesson Corp Annual Shareholders Meeting
Q1 2023 Mckesson Corp Earnings Release
Q2 2023 Mckesson Corp Earnings Release
As of Today at 19:14 UTC, shares in McKesson are trading at $324.24. This share price information is delayed by 15 minutes.
Shares in McKesson last closed at $324.24 and the price had moved by +65.63% over the past 365 days. In terms of relative price strength the McKesson share price has outperformed the S&P500 Index by +71.8% over the past year.
The overall consensus recommendation for McKesson is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The McKesson dividend yield is 0.53% based on the trailing twelve month period.
Last year, McKesson paid a total dividend of $1.73, and it currently has a trailing dividend yield of 0.53%. We do not have any data on when McKesson is to next pay dividends.
We do not have data on when McKesson is to next pay dividends. The historic dividend yield on McKesson shares is currently 0.53%.
To buy shares in McKesson you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $324.24, shares in McKesson had a market capitalisation of $49.51bn.
Here are the trading details for McKesson:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: MCK
Based on an overall assessment of its quality, value and momentum McKesson is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in McKesson is $354.62. That is 9.37% above the last closing price of $324.24.
Analysts covering McKesson currently have a consensus Earnings Per Share (EPS) forecast of $23.86 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like McKesson. Over the past six months, its share price has outperformed the S&P500 Index by +67.83%.
As of the last closing price of $324.24, shares in McKesson were trading +31.22% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The McKesson PE ratio based on its reported earnings over the past 12 months is 13.9. The shares last closed at $324.24.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
McKesson's management team is headed by:
- Edward Mueller - NEC
- Brian Tyler - CEO
- Britt Vitalone - CFO
- Tracy Faber - CHO
- Nancy Flores - EVP
- Lori Schechter - EVP
- Tom Rodgers - EVP
- Kevin Emerson - SVP
- James Hinton - DRC
- Kathleen Wilson - Thompson - DRC
- Richard Carmona - IND
- Dominic Caruso - IND
- Donald Knauss - IND
- Brad Lerman - IND
- Linda Mantia - IND
- Maria Martinez - IND
- Susan Salka - IND